The last update was on the 2nd May pertaining to events in April, hence 3 months of no updates.
Sent this email on the 14th but unfortunately no response;
Hi Kym,
Just touching base as virtually no ANN have been made and little updates on progress.
From my understanding the IND application is in September for both the US and AUST.
Was there a reason for the delay in application from earlier this year.?
Is the manufacturing process and the clinical trial for Cantrixil still on target for later this year?
Anisina toxicology. Will this be ANN and update on progress moving into clinical trial?
Once clinical trials commence will there be more ASX communication’s to Sher’s?
Its also my understanding that many investors have asked for ASX updates. Is there any reason not to provide any; eg, corporate governance, T/O etc?
Hopefully news soon, sentiment is quite low.
Cheers and thanks in advance.
"WTF is going on with this company........." I hear............totally agree.......and we now have a MC of under CR........Irresponsible to let things slip this far, don't you think management regardless of what the lab team are up to. My sentiment of hold is on thin ice with this mob. (management that is)
NRT Price at posting:
10.0¢ Sentiment: Hold Disclosure: Held
